|
|
Line 74: |
Line 74: |
| *Link above to the PDF form of the information presented at: 1st Scientific Summit, Tobacco Harm Reduction, Kallithea, Greece, June 2018 | | *Link above to the PDF form of the information presented at: 1st Scientific Summit, Tobacco Harm Reduction, Kallithea, Greece, June 2018 |
| *Citation: Grant O’Connell1, Tanvir Walele1, Chris Prue1, Gene Gillman, Xavier Cahours, Olivia Hibbert & John D. Pritchard | | *Citation: Grant O’Connell1, Tanvir Walele1, Chris Prue1, Gene Gillman, Xavier Cahours, Olivia Hibbert & John D. Pritchard |
| *Acknowledgement: This work was supported by Fontem Ventures B.V. Imperial Brands plc is the parent company of Fontem Ventures B.V., the manufacturer of the e-cigarette products used in this study.
| |
|
| |
|
| |
|
| |
|
| ===2018 [https://www.sciencedirect.com/science/article/abs/pii/S0021850217301155 Measurements of electronic cigarette-generated particles for the evaluation of lung cancer risk of active and passive users]=== <!--T:15--> | | ===2018 [https://www.sciencedirect.com/science/article/abs/pii/S0021850217301155 Measurements of electronic cigarette-generated particles for the evaluation of lung cancer risk of active and passive users]=== <!--T:15--> |